ArticleEndoscopic ultrasound
EUS point shear-wave elastography: A novel approach for noninvasive liver fibrosis assessment.
Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: EUS point shear‑wave elastography (EUS‑pSWE) permits near‑field, intraluminal assessment of liver stiffness.We examined its concordance with vibration-controlled transient elastography (VCTE) and its diagnostic accuracy for advanced fibrosis (F ≥ 3) in an expanded mixed cohort. Methods: One hundred twenty adults (57% men; mean age: 61 ± 10 years; body mass index: 28.9 ± 4.0) undergoing routine endoscopic ultrasound were prospectively enrolled. VCTE stratified fibrosis as F0-1 (<7.0 kPa, Results: Median EUS‑pSWE increased with fibrosis (left lobe: 5.0 ± 0.9, 7.8 ± 1.0, 15.1 ± 3.4 kPa for F0-1, F2, F3-4; Conclusions: Its high diagnostic accuracy across fibrosis stages and ability to integrate seamlessly into routine EUS make EUS-pSWE a valuable tool for comprehensive liver assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.